Age-related changes in DNA methylation affect renal histology and post-transplant fibrosis.

Line Heylen, Bernard Thienpont, Pieter Busschaert, Ben Sprangers, Dirk Kuypers, Matthieu Moisse, Evelyne Lerut, Diether Lambrechts, Maarten Naesens

Journal: Kidney international 2020;96(5):1195-1204

PMID: 31530476

Abstract

During ageing, kidney function decreases due to renal tubular atrophy, interstitial fibrosis, glomerulosclerosis and arteriosclerosis. Recently, changes in DNA methylation were shown to contribute to various ageing processes. However, it is unknown whether such changes also contribute to age-related kidney dysfunction. To assess this, we profiled genome-wide changes in DNA methylation (over 800 000 CpG sites) in 95 renal biopsies obtained prior to kidney transplantation from donors aged 16 to 73 years. Donor age significantly associated with the methylation of 92 778 CpGs (false discovery rate under 0.05), corresponding to 10 285 differentially methylated regions. These regions were most frequently located in genes involved in the Wnt/beta-catenin signaling pathway. Using an independent cohort of 67 biopsies, we autonomously validated these findings. Interestingly, the methylation status of these 92 778 age-related CpGs was associated with glomerulosclerosis (34.4% of CpGs at a false discovery rate under 0.05) and interstitial fibrosis (0.9%) and graft function at one year after transplantation, but not with tubular atrophy and arteriosclerosis. No association was observed with any of these pathologies at the time of transplantation (0% at a false discovery rate under 0.05). Thus, age-associated changes in DNA methylation at the time of transplantation predict future injury of transplanted kidneys. Specifically, our epigenome-wide association study demonstrates that epigenetic renal ageing is implicated in progressive fibrosis in both the glomerulus and the interstitium.

Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Address: Department of Nephrology, University Hospitals Leuven, Leuven, Belgium; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, VIB Leuven, Leuven, Belgium; Division of Gynecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; Department of Nephrology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Experimental Transplantation, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.; Department of Nephrology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Nephrology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, VIB Leuven, Leuven, Belgium.; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB Leuven, Leuven, Belgium. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.